@article{3a4e065055764afdb60441c57ea0543c,
title = "Oxaliplatin plus fluoropyrimidines as adjuvant therapy for colon cancer in older patients: A subgroup analysis from the TOSCA trial",
abstract = "Background: Previous studies on oxaliplatin and fluoropyrimidines as adjuvant therapy in older patients with stage III colon cancer (CC) produced conflicting results. Patients and methods: We assessed the impact of age on time to tumour recurrence (TTR), disease-free survival (DFS), cancer-specific survival (CSS), and overall survival (OS) in 2360 patients with stage III CC (1667 aged ",
keywords = "Adjuvant chemotherapy, Colon cancer, Compliance, Older patients, Oxaliplatin, Prognostic factors",
author = "S. Lonardi and F. Galli and {Di Bartolomeo}, M. and Monica Ronzoni and Zampino, {Maria G.} and M. Banzi and Silvia Bozzarelli and Garattini, {Silvio K.} and F. Galli and Bochicchio, {Anna M.} and {De Stefano}, Alfonso and G. Rosati and Iaffaioli, {R. V.} and G. Nasti and V. Zagonel and A. Romiti and L. Ciuffreda and D. Ferrari and A. Zaniboni and A. Sobrero and M. Cazzaniga and Beretta, {G. D.} and L. Giustini and S. Cascinu and M. Giordano and M. Moroni and A. Nuzzo and S. Gori and G. Farina and M. Aglietta and R. Franchi and G. Tonini and E. Bucci and A. Ballestrero and Silva, {R. R.} and L. Cozzi and E. Maiello and N. Silvestris and A. Santoro and R. Mattioli and M. D'Amico and D. Amadori and A. Ravaioli and M. Faedi and L. Gianni and L. Pavesi and C. Carlomagno and E. Greco and E. Rulli and F. Galli and D. Poli and L. Porcu and Gerardo Rosati and V. Torri",
note = "Funding Information: This work was supported by AIFA (Agenzia Italiana del Farmaco) [grant no. FARM5RWTWZ ]. Publisher Copyright: {\textcopyright} 2021 Elsevier Ltd Copyright: Copyright 2021 Elsevier B.V., All rights reserved.",
year = "2021",
month = may,
doi = "10.1016/j.ejca.2021.01.051",
language = "English",
volume = "148",
pages = "190--201",
journal = "Eur. J. Cancer",
issn = "0959-8049",
publisher = "Elsevier Ltd",
}